Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 10.521\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] COc1ccc(-c2cn(-c3ccccc3)nc2CO)cc1
[b] CC(=O)NC(Cc1ccccc1)C(=O)NC1CCN(c2ncccc2[N+](=O)[O-])CC1
Answer: b. CC(=O)NC(Cc1ccccc1)C(=O)NC1CCN(c2ncccc2[N+](=O)[O-])CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)NC(Cc1ccccc1)C(=O)NC1CCN(c2ncccc2[N+](=O)[O-])CC1
CC(=O)NC(Cc1ccccc1)C(=O)NC1CCN(c2ncccc2[N+](=O)[O-])CC1
2-acetamido-N-[1-(3-nitropyridin-2-yl)piperidin-4-yl]-3-phenylpropanamide